Peer-reviewedCC BY 4.0Frontiers in Pharmacology
Editorial: Mechanisms of drug resistance in cancer: overcoming barriers with novel pharmacological strategies
4 affiliations
- 1Department of Biological Sciences, SRM University-AP
- 2Dipartimento di Scienze della Salute, Università del Piemonte Orientale
- 3Somaiya Vidyavihar University
- 4Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences Sofia
Related
- Overcoming the Shield: Mechanisms of Resistance to DNA Repair Inhibitors and Strategies to Restore Synthetic Lethality
- Editorial: Cancer and cardiovascular diseases: common mechanisms and strategies of prevention
- Metal-based epigenetic therapeutics in cancer: Mechanisms, targets, and opportunities for overcoming drug resistance
- Inter-organ interaction axes in systemic inflammation: network pathological mechanisms, pharmacological targets, and precision treatment strategies
- Remimazolam for Precision Sedation and Anaesthesia in Vulnerable Populations: A Narrative Review of Pharmacological Mechanisms, Stratified Clinical Evidence, and Individualised Perioperative Strategies
BibTeX
@article{kar2026editorial,
title = {{Editorial: Mechanisms of drug resistance in cancer: overcoming barriers with novel pharmacological strategies}},
author = {Pulak Kar and Donato Colangelo and Maushmi Shailesh Kumar and Maya Guncheva},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1996202},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1996202/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Mechanisms of drug resistance in cancer: overcoming barriers with novel pharmacological strategies
AU - Pulak Kar
AU - Donato Colangelo
AU - Maushmi Shailesh Kumar
AU - Maya Guncheva
PY - 2026
DA - 2026/10/21
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1996202
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1996202/full
SN - 1663-9812
ER -